Jana Care
Private Company
Total funding raised: $17.8M
Overview
Jana Care is a private, pre-revenue diagnostics company pioneering a low-cost, smartphone-integrated platform for decentralized chronic disease monitoring. Its three-part approach involves paper-based test strips, a smartphone accessory reader, and a connected data ecosystem to link patients with clinicians. Initially focused on Congestive Heart Failure (CHF) and Chronic Kidney Disease (CKD), the company has deployed its technology in over 1,500 clinics, serving more than 200,000 patients primarily in India, though its device is not yet FDA-cleared or commercially available in the US. The business model targets prescription-based testing to identify patients needing clinical follow-up, aiming to improve outcomes and reduce costly hospitalizations.
Technology Platform
Integrated diagnostic system combining proprietary paper-based microfluidic test strips with a smartphone-based reader device (Aina) and a connected software platform for remote patient monitoring and telehealth integration.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Jana Care competes in the remote patient monitoring and point-of-care diagnostics space. Key competitors include established diagnostics companies (e.g., Abbott, Roche) with handheld readers, digital health startups offering connected devices, and traditional telehealth platforms. Jana Care's differentiation is its ultra-low-cost paper-and-smartphone model, targeting affordability and scalability.